Thermo Fisher Stock Surges as Medical Device Maker's Results Top Estimates

Core Insights - Thermo Fisher Scientific's shares rose after the company reported fourth-quarter results that exceeded analysts' expectations [1][2] - The company achieved revenue of $11.4 billion, representing a year-over-year increase of approximately 5%, surpassing the Visible Alpha consensus of $11.28 billion [1] - Profit for the quarter was reported at $1.83 billion, or $4.78 per share, which is an increase from $4.20 per share a year ago [1] - Adjusted earnings per share (EPS) of $6.10 also exceeded expectations [1] Revenue Performance - Sales increased across all four divisions of the company, with the largest segment, Laboratory Products and Biopharma Services, seeing a revenue rise of 4% [2] - This performance contrasts with the previous quarter, where sales were flat or declined in two segments [2] Stock Performance - Following the positive earnings report, Thermo Fisher's shares experienced a 6.6% intraday increase, after being roughly flat over the prior 12 months [2]